BioCentury | Jan 12, 2021
Product Development

OX40L pipeline: Data Byte

...Phase II trial in ovarian cancer patients.DNAtrix Inc. is investigating an adenovirus engineered to express OX40L, while Sichuan Clover Biopharmaceuticals Inc....
BioCentury | Dec 9, 2020
Product Development

Dec. 8 COVID Quick Takes: U.K. Vaccines Taskforce to test combinations, plus advances from Clover, Lilly and India’s Serum Institute

...government formally requested two weeks ago that MHRA start reviewing AZD1222. Clover starting two pivotal vaccine studiesSichuan Clover Biopharmaceuticals...
BioCentury | Nov 18, 2020
Product Development

COVID-19 Quick Takes: EMA to require more stringent safety monitoring for vaccines; plus J&J, Clover-Thousand Oaks, Medicago-GSK, Inovio and Synairgen

...$604 million and BARDA $454 million to conduct ENSEMBLE.Clover partners with Thousand Oaks on vaccineSichuan Clover Biopharmaceuticals...
BioCentury | Jul 9, 2020
Product Development

CSL testing coagulation factor blocker in COVID-19 patients; plus vaccine deals and plasma trials

...hereditary angioedema. COVID-19 vaccines The Coalition for Epidemic Preparedness Innovations (CEPI) said it would grant Sichuan Clover Biopharmaceuticals Inc....
...Lung Delivery” ). BioCentury Staff garadacimab (CSL312) COVID-19 S-Trimer (SCB-2019) CpG 1018 Medicago-COVID-19-unknown COVID-HIG Veklury, remdesivir (GS-5734) CSL Ltd. Coalition for Epidemic Preparedness Innovations (CEPI) Sichuan Clover Biopharmaceuticals Inc. GlaxoSmithKline...
BioCentury | Jun 23, 2020
Product Development

Daily Chart: More vaccine, therapeutic trial starts

...In the past week, 20 additional therapeutics entered the clinic, bringing the total to 318. Sichuan Clover Biopharmaceuticals Inc....
BioCentury | Jun 20, 2020
Product Development

Daily Chart: COVID-19 vaccines by phase and modality

...Among the 157 COVID-19 vaccines in development, at least 18 have reached the clinic. Sichuan Clover Biopharmaceuticals Inc. is...
BioCentury | Jun 19, 2020
Politics, Policy & Law

House lawmakers call for transparency, independent review for COVID-19 vaccine program

...transparent, and involves independent review and interagency cooperation. The demands for vaccine transparency come as Sichuan Clover Biopharmaceuticals Inc....
...Innovations (see “Clover: Trimerizing Fusion Proteins” ). Elizabeth S. Eaton, Staff Writer U.S. Food and Drug Administration (FDA) Sichuan Clover Biopharmaceuticals Inc. covid-19 cov19pol vaccine transparency oversight cov19pol...
BioCentury | Jun 9, 2020
Finance

June 8 Financial Quick Takes: Novo’s REPAIR fund issues call for AMR proposals; B rounds for MabPlex, Clover; A rounds for Shorla, Curesponse

...and a manufacturing site in Yantai, where it is headquartered. Clover raises $24M series B-2 Sichuan Clover Biopharmaceuticals Inc....
...opening of a U.K. laboratory to begin additional clinical trials. Targets Target1 Target2 BioCentury Staff MabPlex International Ltd. Sichuan Clover Biopharmaceuticals Inc. REPAIR...
BioCentury | May 20, 2020
Product Development

BARDA takes steps to secure supply chain as more companies look to scale up manufacturing

...with the Coalition for Epidemic Preparedness Innovations (CEPI). Its partners include the University of Queensland, Sichuan Clover Biopharmaceuticals Inc....
BioCentury | May 9, 2020
Product Development

China emerging as a leader in COVID-19 vaccines

...and Stemirna Therapeutics Co. Ltd. At least two Chinese groups, Shenzhen Genoimmune Medical Institute and Sichuan Clover Biopharmaceuticals Inc....
Items per page:
1 - 10 of 20
BioCentury | Jan 12, 2021
Product Development

OX40L pipeline: Data Byte

...Phase II trial in ovarian cancer patients.DNAtrix Inc. is investigating an adenovirus engineered to express OX40L, while Sichuan Clover Biopharmaceuticals Inc....
BioCentury | Dec 9, 2020
Product Development

Dec. 8 COVID Quick Takes: U.K. Vaccines Taskforce to test combinations, plus advances from Clover, Lilly and India’s Serum Institute

...government formally requested two weeks ago that MHRA start reviewing AZD1222. Clover starting two pivotal vaccine studiesSichuan Clover Biopharmaceuticals...
BioCentury | Nov 18, 2020
Product Development

COVID-19 Quick Takes: EMA to require more stringent safety monitoring for vaccines; plus J&J, Clover-Thousand Oaks, Medicago-GSK, Inovio and Synairgen

...$604 million and BARDA $454 million to conduct ENSEMBLE.Clover partners with Thousand Oaks on vaccineSichuan Clover Biopharmaceuticals...
BioCentury | Jul 9, 2020
Product Development

CSL testing coagulation factor blocker in COVID-19 patients; plus vaccine deals and plasma trials

...hereditary angioedema. COVID-19 vaccines The Coalition for Epidemic Preparedness Innovations (CEPI) said it would grant Sichuan Clover Biopharmaceuticals Inc....
...Lung Delivery” ). BioCentury Staff garadacimab (CSL312) COVID-19 S-Trimer (SCB-2019) CpG 1018 Medicago-COVID-19-unknown COVID-HIG Veklury, remdesivir (GS-5734) CSL Ltd. Coalition for Epidemic Preparedness Innovations (CEPI) Sichuan Clover Biopharmaceuticals Inc. GlaxoSmithKline...
BioCentury | Jun 23, 2020
Product Development

Daily Chart: More vaccine, therapeutic trial starts

...In the past week, 20 additional therapeutics entered the clinic, bringing the total to 318. Sichuan Clover Biopharmaceuticals Inc....
BioCentury | Jun 20, 2020
Product Development

Daily Chart: COVID-19 vaccines by phase and modality

...Among the 157 COVID-19 vaccines in development, at least 18 have reached the clinic. Sichuan Clover Biopharmaceuticals Inc. is...
BioCentury | Jun 19, 2020
Politics, Policy & Law

House lawmakers call for transparency, independent review for COVID-19 vaccine program

...transparent, and involves independent review and interagency cooperation. The demands for vaccine transparency come as Sichuan Clover Biopharmaceuticals Inc....
...Innovations (see “Clover: Trimerizing Fusion Proteins” ). Elizabeth S. Eaton, Staff Writer U.S. Food and Drug Administration (FDA) Sichuan Clover Biopharmaceuticals Inc. covid-19 cov19pol vaccine transparency oversight cov19pol...
BioCentury | Jun 9, 2020
Finance

June 8 Financial Quick Takes: Novo’s REPAIR fund issues call for AMR proposals; B rounds for MabPlex, Clover; A rounds for Shorla, Curesponse

...and a manufacturing site in Yantai, where it is headquartered. Clover raises $24M series B-2 Sichuan Clover Biopharmaceuticals Inc....
...opening of a U.K. laboratory to begin additional clinical trials. Targets Target1 Target2 BioCentury Staff MabPlex International Ltd. Sichuan Clover Biopharmaceuticals Inc. REPAIR...
BioCentury | May 20, 2020
Product Development

BARDA takes steps to secure supply chain as more companies look to scale up manufacturing

...with the Coalition for Epidemic Preparedness Innovations (CEPI). Its partners include the University of Queensland, Sichuan Clover Biopharmaceuticals Inc....
BioCentury | May 9, 2020
Product Development

China emerging as a leader in COVID-19 vaccines

...and Stemirna Therapeutics Co. Ltd. At least two Chinese groups, Shenzhen Genoimmune Medical Institute and Sichuan Clover Biopharmaceuticals Inc....
Items per page:
1 - 10 of 20